相关实验视频
Updated: May 16, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
17.7K
在RCC管理中的基因组:集中治疗的新前沿
Etan Eigner1, Kamil Malshy2, Jathin Bandari2
1Department of Urology, Rambam Health Care Campus, Haifa, Israel.
Clinical genitourinary cancer
|May 14, 2025
概括
基因组,一种超声波技术,可以在没有热量的情况下机械地破坏瘤. 临床试验正在评估其对固体瘤的安全性和有效性,提供一种非侵入性治疗选择.
科学领域:
- 在瘤学瘤学.
- 医学超声波 医学超声波
- 生物物理学的生物物理.
背景情况:
- 组织缩是一种非侵入性的,基于超声波的组织切除技术.
- 它使用聚焦的高强度声波来机械地分解组织.
- 这种方法避免了热损伤,使其与其他基于能量的疗法区别开来.
研究的目的:
- 审查基因组囊作为固体瘤的非侵入性治疗的潜力.
- 突出其在瘤疾病,特别是脏瘤中的应用.
- 讨论正在进行的临床试验,评估基因组的安全性和有效性.
主要方法:
- 组织缩利用聚焦超声波来诱导腔位,在目标组织中形成微泡.
- 这些微泡膨胀和崩,造成机械应激,导致细胞死亡和组织分裂.
- 该技术精确地准病变,同时不影响周围的健康组织.
主要成果:
- 在各种固体瘤模型中进行的临床前研究显示出有希望的结果,包括瘤减少和改善生存率.
- 组织缩显示出在关键结构附近或不适合手术的患者中治疗瘤的潜力.
- 目前正在进行早期临床试验,以评估初级固体瘤的安全性和有效性.
结论:
- 基因组瘤为固体瘤提供了一个有前途的非侵入性治疗选择,包括细胞癌 (RCC).
- 它能够在没有热损伤的情况下选择性地切除组织,这比传统治疗方法具有优势.
- 需要进一步的临床证据来建立最佳的方案和患者选择,以便广泛采用.
更多相关视频
05:31Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
5.4K
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.2K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K